New Natroba clinical trial entry

Created on 20.08.12

A new record for a Natroba clinical trial is available on the US Clinical Trials registry.

The study looks at the pharmacokinetics and tolerance of a topical suspension of Natroba (Spinosad, 0.9%) on young children infected with head lice. The start date for the study was September 2011.

This is a Phase 4, post-marketing requirement study involving 26 enrolled subjects, who each received a 10 minute application of the Natroba suspensions before removal by rinsing. No results have yet been posted although the study is marked as completed.

Updates will be posted as new information becomes available. 




Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 — all rights reserved